Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation, 28664-28668 [2018-13221]
Download as PDF
<![CDATA[
28664
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chem
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 20, 2018.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
SUPPLEMENTARY INFORMATION:
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
13, 2018, American Radiolabeled Chem,
101 Arc Drive, St. Louis, MO 63146
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Ibogaine ...................................................................................................................................................................
Lysergic acid diethylamide ......................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
Dihydromorphine ......................................................................................................................................................
Heroin ......................................................................................................................................................................
Normorphine ............................................................................................................................................................
Amphetamine ...........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Amobarbital ..............................................................................................................................................................
Phencyclidine ...........................................................................................................................................................
Phenylacetone .........................................................................................................................................................
Cocaine ....................................................................................................................................................................
Codeine ....................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ...............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Hydrocodone ............................................................................................................................................................
Meperidine ...............................................................................................................................................................
Metazocine ...............................................................................................................................................................
Methadone ...............................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Oripavine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Phenazocine ............................................................................................................................................................
Carfentanil ................................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacture
small quantities of the above-listed
controlled substances as radiolabeled
compounds for biochemical research.
Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2018–13231 Filed 6–19–18; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 20, 2018.
DATES:
VerDate Sep<11>2014
17:58 Jun 19, 2018
Jkt 244001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
DEPARTMENT OF JUSTICE
ACTION:
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
9300
9330
9333
9652
9715
9743
9801
Schedule
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
SUPPLEMENTARY INFORMATION:
E:\FR\FM\20JNN1.SGM
20JNN1
28665
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on May
4th, 2018, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock,
Texas 78665 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .............................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) ...............................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
N,N-Dimethylamphetamine ..............................................................................................................................................
Fenethylline .....................................................................................................................................................................
Aminorex ..........................................................................................................................................................................
4-Methylaminorex (cis isomer) ........................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Methaqualone ..................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ...................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) .................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ......................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................
FUB–AMB, MMB-Fubinaca 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate ...............................
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ...................................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide .................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ..............................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................
MDMB–CHMICA,
MMB–CHMINACA
(Methyl
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ..............................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..................................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) ....................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) ......................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) .......................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..........................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) ........................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) .......................................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................
Alpha-ethyltryptamine ......................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ..........................................
Lysergic acid diethylamide ..............................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ..............................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Parahexyl .........................................................................................................................................................................
Mescaline .........................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) ...........................................................................................
3,4,5-Trimethoxyamphetamine ........................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) .......................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
VerDate Sep<11>2014
17:58 Jun 19, 2018
Jkt 244001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\20JNN1.SGM
20JNN1
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
6250
7008
7010
7011
7012
7019
7020
7021
7023
7024
7031
7032
7033
7034
7035
7042
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7048
7049
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7297
7298
7315
7348
7360
7370
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
28666
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
4-Methoxyamphetamine ..................................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................
Alpha-methyltryptamine ...................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ....................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ....................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .....................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ..................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ....................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) .................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) ..................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ....................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) .............................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ..................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ....................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ....................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) .........................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..........................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) ....................................................................................................
Acetyldihydrocodeine .......................................................................................................................................................
Benzylmorphine ...............................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Desomorphine .................................................................................................................................................................
Codeine methylbromide ...................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Heroin ..............................................................................................................................................................................
Hydromorphinol ...............................................................................................................................................................
Methyldesorphine ............................................................................................................................................................
Methyldihydromorphine ...................................................................................................................................................
Morphine methylbromide .................................................................................................................................................
Morphine methylsulfonate ...............................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Normorphine ....................................................................................................................................................................
Pholcodine .......................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ..............................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) ...................................................................
MT45 ................................................................................................................................................................................
Acetylmethadol ................................................................................................................................................................
Allylprodine ......................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ......................................................................................................
Alphameprodine ...............................................................................................................................................................
Alphamethadol .................................................................................................................................................................
Betacetylmethadol ...........................................................................................................................................................
Betameprodine ................................................................................................................................................................
Betamethadol ...................................................................................................................................................................
Betaprodine .....................................................................................................................................................................
Dipipanone .......................................................................................................................................................................
Hydroxypethidine .............................................................................................................................................................
Noracymethadol ...............................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Normethadone .................................................................................................................................................................
Trimeperidine ...................................................................................................................................................................
Phenomorphan ................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ......................................................................................................................
Tilidine .............................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .................................................................................
Para-Fluorofentanyl .........................................................................................................................................................
3-Methylfentanyl ..............................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl-alpha-methylfentanyl .............................................................................................................................................
Orthofluorofentanyl N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4yl)propionamide .........................................................
VerDate Sep<11>2014
17:58 Jun 19, 2018
Jkt 244001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\20JNN1.SGM
20JNN1
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7470
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9051
9052
9053
9055
9070
9145
9200
9301
9302
9304
9305
9306
9307
9313
9314
9547
9551
9560
9601
9602
9603
9604
9605
9607
9608
9609
9611
9622
9627
9633
9634
9635
9646
9647
9661
9750
9811
9812
9813
9814
9815
9816
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
28667
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Butyryl Fentanyl ...............................................................................................................................................................
Para-Fluorobutyrl Fentanyl ..............................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .........................................
Methoxyacetyl Fentanyl 2-methoxy-N-(1-phenethylpiperidin-4-yl)-Nphenylacetamide ...................................................
Para-Chloroisobutyrl Fentanyl .........................................................................................................................................
Isobutyryl Fentanyl ..........................................................................................................................................................
Beta-hydroxyfentanyl .......................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ........................................................................................................................................
Alpha-methylthiofentanyl .................................................................................................................................................
3-Methylthiofentanyl .........................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .............................................................
Thiofentanyl .....................................................................................................................................................................
Beta-hydroxythiofentanyl .................................................................................................................................................
Para-methoxybutyryl fentanyl ..........................................................................................................................................
Ocfentanil .........................................................................................................................................................................
Valeryl Fentanyl ...............................................................................................................................................................
Tetrahydrofuranyl Fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran2-carboxamide ...............................
Cyclopropyl Fentanyl .......................................................................................................................................................
Cyclopentyl fentanyl ........................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .....................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
1-Phenylcyclohexylamine ................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
1-Piperidinocyclohexanecarbonitrile ................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Isomethadone ..................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-A ..............................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Metazocine ......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Thiafentanil ......................................................................................................................................................................
Racemethorphan .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
VerDate Sep<11>2014
17:58 Jun 19, 2018
Jkt 244001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
E:\FR\FM\20JNN1.SGM
20JNN1
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8603
9010
9041
9050
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9273
9300
9333
9648
9652
9668
9729
9732
9737
9739
9740
9743
9780
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
28668
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
which will be distributed to its
customers.
Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–13221 Filed 6–19–18; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL SCIENCE FOUNDATION
Request for Information—
Environmental Research and
Education, National Security, and
Economic Competitiveness
National Science Foundation.
Notice of Request for
Information.
AGENCY:
ACTION:
The purpose of this Request
for Information (RFI) is to seek input
from the public on possible future
directions for fundamental
environmental science and education.
The RFI intends to gather views from
external stakeholders on what
environmental research and education
is needed to further advance national
security and economic competitiveness.
NSF’s Advisory Committee for
Environmental Research and Education
(AC ERE) will use the input to develop
a report on these topics to inform NSF
and the community.
DATES: Written comments must be
submitted by August 20, 2018.
ADDRESSES: Responses will be
submitted via online survey (https://
www.surveymonkey.com/r/ACERE-RFI2018). See the instructions in the
SUPPLEMENTARY INFORMATION for
guidelines.
FOR FURTHER INFORMATION CONTACT:
Contact Leah Nichols, Executive
Secretary for the AC ERE, at lenichol@
nsf.gov for further information.
SUPPLEMENTARY INFORMATION: The
National Science Foundation’s Advisory
Committee for Environmental Research
and Education (AC ERE) invites your
input on possible environmental
research and education directions to
further advance national security and
economic competitiveness. The purpose
of the AC ERE is to:
• Provide advice, recommendations
and oversight concerning support for
the NSF’s environmental research and
education portfolio;
• Be a base of contact with the
scientific community to inform NSF of
the impact of its research support and
NSF-wide policies on the scientific
community;
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:58 Jun 19, 2018
Jkt 244001
• Serve as a forum for consideration
of interdisciplinary environmental
topics as well as environmental
activities in a wide range of disciplines;
• Provide broad input into long-range
plans and partnership opportunities;
and
• Provide advice about program
management, overall program balance,
and other aspects of program
performance for environmental research
and education activities.
The Committee has been interested
broadly in fundamental environmental
research and education that also has
societal utility. It has recently focused
its attention on two major topics where
there is broad consensus on the
importance of the research to date, but
where significant research questions
remain. These topics are at the nexus of
environmental science and engineering
with economic growth and
competitiveness, and the relationship of
environmental factors to national and
human security. The Committee is
particularly interested in approaches
that promote convergent research across
disciplines and sectors to address
economic competitiveness and
economic security.
To identify emerging research
questions in these areas, the committee
is reaching out to interested and
knowledgeable members of the
scientific community in all disciplines
and interdisciplinary areas for their
views. The AC ERE is also interested in
the views of professionals who are
directly involved in decision-making or
operational activities in these areas, and
who therefore can provide a very
practical perspective on high-priority
research and education topics.
The AC ERE invites individuals and
groups of individuals to provide input
on one or both of the topics described
above via this link: https://
www.surveymonkey.com/r/ACERE-RFI2018.
The online submission form requires
the following information:
1. Author name(s) and affiliation(s);
2. Valid contact email address;
3. Title of the response;
4. An abstract (200 words or less)
summarizing the response; and
5. Checkbox to consent to allow the
AC ERE to display the submitted
information, consistent with the
Creative Commons AttributionNonCommercial-NoDerivatives 4.0
International License (https://
creativecommons.org/licenses/by-nc-nd/
4.0/legalcode).
You will also be asked to identify
whether your response focuses on
questions in environmental research
and education that are pertinent to (a)
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
economic growth and competitiveness,
(b) national and human security, or (c)
both topics. The submission form
includes the following question
prompts. Respondents may respond to
all or any subset of these questions.
• What are the major environmental
research priorities with the greatest
potential to contribute to economic
growth and competitiveness and/or
national or human security/wellbeing?
Priorities could, for example, include
empirical, theoretical, or qualitative
analyses, establishing baselines, and/or
experimental studies. (500 words or
less)
• What methodologies should be used
for conducting such studies?
Methodological recommendations could
include the prospects for
interdisciplinary and/or convergent
research approaches, including
modeling, theory, empirical, qualitative,
and/or experimental studies.
Methodological recommendations could
also discuss the scope of studies, e.g. the
balance between single-investigator
studies and large teams. (500 words or
less)
• What education (including formal
and informal), research, and training
opportunities—for students,
postdoctoral researchers, and mid-career
scientists—are needed? Opportunities
might include interdisciplinary, teambased, or other innovative, value-added
strategies for realizing higher levels of
depth and breadth at the individual
level, and/or expansion of the current
environmental research community
through inclusion of currently underrepresented groups. (500 words or less)
• Beyond economic competitiveness
and national security, what other high
priority drivers of environmental
science and education need attention?
(200 words or less)
Submissions must be received by 5:00
p.m. Eastern Time on August 20, 2018.
Respondents may edit their responses
while completing the survey, but will
not be able to save work in progress to
complete later. Respondents will see a
confirmation screen upon successful
submission responses.
The committee and associated staff
will read and analyze all responses
received, and use them, in addition to
its own background work, to develop a
report on these topics to inform NSF
and the community. It intends to
publish this report by the end of 2018.
The AC ERE also anticipates making
submissions publicly accessible through
its website (https://www.nsf.gov/ere/
ereweb/advisory.jsp). Authors who do
not wish to have their full responses
posted online may restrict access to the
AC ERE and associated staff. However,
E:\FR\FM\20JNN1.SGM
20JNN1
]]>Agencies
[Federal Register Volume 83, Number 119 (Wednesday, June 20, 2018)]
[Notices]
[Pages 28664-28668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13221]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application:
Cerilliant Corporation
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 20, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers,
[[Page 28665]]
importers, and exporters of controlled substances (other than final
orders in connection with suspension, denial, or revocation of
registration) has been delegated to the Assistant Administrator of the
DEA Diversion Control Division (``Assistant Administrator'') pursuant
to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on May
4th, 2018, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round
Rock, Texas 78665 applied to be registered as a bulk manufacturer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)....... 1233 I
Cathinone................................ 1235 I
Methcathinone............................ 1237 I
4-Fluoro-N-methylcathinone (4-FMC)....... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone).. 1248 I
4-Methyl-N-ethylcathinone (4-MEC)........ 1249 I
Naphyrone................................ 1258 I
N-Ethylamphetamine....................... 1475 I
N,N-Dimethylamphetamine.................. 1480 I
Fenethylline............................. 1503 I
Aminorex................................. 1585 I
4-Methylaminorex (cis isomer)............ 1590 I
Gamma Hydroxybutyric Acid................ 2010 I
Methaqualone............................. 2565 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl)indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl)indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).. 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
FUB-AMB, MMB-Fubinaca 2-(1-(4- 7021 I
fluorobenzyl)-1Hindazole-3-carboxamido)-
3-methylbutanoate.
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan- 7023 I
2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone.
AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazole-3-carboxamido)-3-
methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)- 7049 I
1-(5-fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I
[(4-methoxy)-benzoyl]indole).
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl)indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).. 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl)indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-carboxylate).
Alpha-ethyltryptamine.................... 7249 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide............... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Marihuana................................ 7360 I
Tetrahydrocannabinols.................... 7370 I
Parahexyl................................ 7374 I
Mescaline................................ 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2).
3,4,5-Trimethoxyamphetamine.............. 7390 I
4-Bromo-2,5-dimethoxyamphetamine......... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine...... 7392 I
4-Methyl-2,5-dimethoxyamphetamine........ 7395 I
2,5-Dimethoxyamphetamine................. 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl)indole).
2,5-Dimethoxy-4-ethylamphetamine......... 7399 I
3,4-Methylenedioxyamphetamine............ 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine.. 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine.. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine.... 7404 I
3,4-Methylenedioxymethamphetamine........ 7405 I
[[Page 28666]]
4-Methoxyamphetamine..................... 7411 I
5-Methoxy-N-N-dimethyltryptamine......... 7431 I
Alpha-methyltryptamine................... 7432 I
Bufotenine............................... 7433 I
Diethyltryptamine........................ 7434 I
Dimethyltryptamine....................... 7435 I
Psilocybin............................... 7437 I
Psilocyn................................. 7438 I
5-Methoxy-N,N-diisopropyltryptamine...... 7439 I
N-Ethyl-1-phenylcyclohexylamine.......... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine........ 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine.... 7470 I
N-Benzylpiperazine....................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone (4- 7498 I
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine 7518 I
(2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I
ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone).... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone................................. 7541 I
Pentylone................................ 7542 I
alpha-pyrrolidinopentiophenone ([alpha]- 7545 I
PVP).
alpha-pyrrolidinobutiophenone ([alpha]- 7546 I
PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl)indole).
Acetyldihydrocodeine..................... 9051 I
Benzylmorphine........................... 9052 I
Codeine-N-oxide.......................... 9053 I
Desomorphine............................. 9055 I
Codeine methylbromide.................... 9070 I
Dihydromorphine.......................... 9145 I
Heroin................................... 9200 I
Hydromorphinol........................... 9301 I
Methyldesorphine......................... 9302 I
Methyldihydromorphine.................... 9304 I
Morphine methylbromide................... 9305 I
Morphine methylsulfonate................. 9306 I
Morphine-N-oxide......................... 9307 I
Normorphine.............................. 9313 I
Pholcodine............................... 9314 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide
).
MT45..................................... 9560 I
Acetylmethadol........................... 9601 I
Allylprodine............................. 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine........................... 9604 I
Alphamethadol............................ 9605 I
Betacetylmethadol........................ 9607 I
Betameprodine............................ 9608 I
Betamethadol............................. 9609 I
Betaprodine.............................. 9611 I
Dipipanone............................... 9622 I
Hydroxypethidine......................... 9627 I
Noracymethadol........................... 9633 I
Norlevorphanol........................... 9634 I
Normethadone............................. 9635 I
Trimeperidine............................ 9646 I
Phenomorphan............................. 9647 I
1-Methyl-4-phenyl-4-propionoxypiperidine. 9661 I
Tilidine................................. 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin-4- 9811 I
yl)-N-phenylacrylamide).
Para-Fluorofentanyl...................... 9812 I
3-Methylfentanyl......................... 9813 I
Alpha-methylfentanyl..................... 9814 I
Acetyl-alpha-methylfentanyl.............. 9815 I
Orthofluorofentanyl N-(2-fluorophenyl)-N- 9816 I
(1-phenethylpiperidin-4yl)propionamide.
[[Page 28667]]
Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I
4-yl)-N-phenylacetamide).
Butyryl Fentanyl......................... 9822 I
Para-Fluorobutyrl Fentanyl............... 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
Methoxyacetyl Fentanyl 2-methoxy-N-(1- 9825 I
phenethylpiperidin-4-yl)-
Nphenylacetamide.
Para-Chloroisobutyrl Fentanyl............ 9826 I
Isobutyryl Fentanyl...................... 9827 I
Beta-hydroxyfentanyl..................... 9830 I
Beta-hydroxy-3-methylfentanyl............ 9831 I
Alpha-methylthiofentanyl................. 9832 I
3-Methylthiofentanyl..................... 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin- 9834 I
4-yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl............................. 9835 I
Beta-hydroxythiofentanyl................. 9836 I
Para-methoxybutyryl fentanyl............. 9837 I
Ocfentanil............................... 9838 I
Valeryl Fentanyl......................... 9840 I
Tetrahydrofuranyl Fentanyl N-(1- 9843 I
phenethylpiperidin-4-yl)-N-
phenyltetrahydrofuran2-carboxamide.
Cyclopropyl Fentanyl..................... 9845 I
Cyclopentyl fentanyl..................... 9847 I
Fentanyl related-compounds as defined in 9850 I
21 CFR 1308.11(h).
Amphetamine.............................. 1100 II
Methamphetamine.......................... 1105 II
Lisdexamfetamine......................... 1205 II
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Nabilone................................. 7379 II
1-Phenylcyclohexylamine.................. 7460 II
Phencyclidine............................ 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II
1-Piperidinocyclohexanecarbonitrile...... 8603 II
Alphaprodine............................. 9010 II
Cocaine.................................. 9041 II
Codeine.................................. 9050 II
Dihydrocodeine........................... 9120 II
Oxycodone................................ 9143 II
Hydromorphone............................ 9150 II
Diphenoxylate............................ 9170 II
Ecgonine................................. 9180 II
Ethylmorphine............................ 9190 II
Hydrocodone.............................. 9193 II
Levomethorphan........................... 9210 II
Levorphanol.............................. 9220 II
Isomethadone............................. 9226 II
Meperidine............................... 9230 II
Meperidine intermediate-A................ 9232 II
Meperidine intermediate-B................ 9233 II
Meperidine intermediate-C................ 9234 II
Metazocine............................... 9240 II
Methadone................................ 9250 II
Methadone intermediate................... 9254 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine................................. 9300 II
Thebaine................................. 9333 II
Levo-alphacetylmethadol.................. 9648 II
Oxymorphone.............................. 9652 II
Noroxymorphone........................... 9668 II
Thiafentanil............................. 9729 II
Racemethorphan........................... 9732 II
Alfentanil............................... 9737 II
Remifentanil............................. 9739 II
Sufentanil............................... 9740 II
Carfentanil.............................. 9743 II
Tapentadol............................... 9780 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
[[Page 28668]]
The company plans to manufacture small quantities of the listed
controlled substances to make reference standards which will be
distributed to its customers.
Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-13221 Filed 6-19-18; 8:45 am]
BILLING CODE 4410-09-P
